Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novasoy, Gemcitabine, and Erlotinib in Pancreatic Cancer
NCT00376948Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- May 2005
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of genistein in pancreatic adenocarcinoma (PDAC), sponsored by Barbara Ann Karmanos Cancer Institute. Started May 2005; status: completed.
02
Drugs
genistein
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00376948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376948.